scholarly journals Potentially Inappropriate Prescribing Among People with Dementia in Primary Care: A Retrospective Cross-Sectional Study Using the Enhanced Prescribing Database

2016 ◽  
Vol 52 (4) ◽  
pp. 1503-1513 ◽  
Author(s):  
Heather E. Barry ◽  
Janine A. Cooper ◽  
Cristín Ryan ◽  
A. Peter Passmore ◽  
A. Louise Robinson ◽  
...  
2021 ◽  
Vol 60 (1) ◽  
pp. 6-6

AbstractOverview of: Khatter A, Moriarty F, Ashworth M et al. Prevalence and predictors of potentially inappropriate prescribing in middle-aged adults: a repeated cross-sectional study. Br J Gen Pract. 2021;71:e491–e497.


BMJ Open ◽  
2018 ◽  
Vol 8 (10) ◽  
pp. e022876 ◽  
Author(s):  
Emma Barry ◽  
Frank Moriarty ◽  
Fiona Boland ◽  
Kathleen Bennett ◽  
Susan M Smith

ObjectivesEvidence is limited regarding the quality of prescribing to children. The objective of this study was to apply a set of explicit prescribing indicators to a national pharmacy claims database (Primary Care Reimbursement Service) to determine the prevalence of potentially inappropriate prescribing in children (PIPc) in primary care.Primary and secondary outcomes measuresTo determine the overall prevalence of potentially inappropriate prescribing (PIP) in children in primary care. To examine the prevalence of PIPc by gender.Design and settingCross-sectional study. Application of indicators of commission of PIP and omission of appropriate prescribing to a national prescribing database in Ireland.ParticipantsEligible children <16 years of age who were prescribed medication in 2014.ResultsOverall prevalence of PIPc by commission was 3.5% (95% CI 3.5% to 3.6%) of eligible children <16 years of age who were prescribed medication in 2014. Overall prevalence of PIPc by omission was 2.5% (95% CI 2.5% to 2.6%) which rose to 11.5% (95% CI 11.4% to 11.7%) when prescribing of spacer devices for children with asthma was included. The most common individual PIPc by commission was the prescribing of carbocisteine to children (3.3% of eligible children). The most common PIPc by omission (after excluding spacer devices) was failure to prescribe an emollient to children prescribed greater than one topical corticosteroid (54% of eligible children). PIPc by omission was significantly higher in males compared with females (relative risk (RR) 1.3; 95% CI 1.0 to 1.7) but no different for PIPc by commission (RR 1.0; 95% CI 0.7 to 1.6).ConclusionThis study shows that the overall prevalence of PIP in children is low, although results suggest room for improved adherence to asthma guidelines.


2017 ◽  
Vol 39 (2) ◽  
pp. 386-393 ◽  
Author(s):  
Ana Luiza Pereira Moreira Mori ◽  
Renata Cunha Carvalho ◽  
Patricia Melo Aguiar ◽  
Maria Goretti Farias de Lima ◽  
Magali da Silva Pacheco Nobre Rossi ◽  
...  

2021 ◽  
Vol 139 (2) ◽  
pp. 107-116
Author(s):  
Welma Wildes Amorim ◽  
Luiz Carlos Passos ◽  
Romana Santos Gama ◽  
Renato Morais Souza ◽  
Lucas Teixeira Graia ◽  
...  

2021 ◽  
pp. BJGP.2020.1048
Author(s):  
Amandeep Khatter ◽  
Frank Moriarty ◽  
Mark Ashworth ◽  
Stevo Durbaba ◽  
Patrick Redmond

Background: Potentially inappropriate prescribing (PIP) is common in older adults and known to be associated with polypharmacy and multimorbidity. Less is known about the prevalence and causes of PIP in middle-aged adults. Aim: To determine the prevalence and predictors of PIP in middle-aged adults. Design and Setting: A repeated cross-sectional study was conducted using primary care data in London. Method: PIP was defined using the PRescribing Optimally in Middle-aged People’s Treatment (PROMPT) criteria. Prescribing and demographic data were extracted from Lambeth DataNet (LDN), a pseudonymised database of all patients registered at general practices in Lambeth, for those aged 45-64 years prescribed ≥1 medicines in each year, 2014-2019 (n=46,633-52,582). Prevalence and trends over six years were investigated, including the association of PIP with polypharmacy, multimorbidity, deprivation, gender and age. Results: The prevalence of PIP decreased from 20% in 2014 to 18% in 2019. The most prevalent PROMPT criteria in 2019 were the use of ≥2 drugs from the same pharmacological class (7.6%), use of NSAIDs for >3 months (7%) and use of PPIs above recommended maintenance dosages for >8 weeks (3%). Over the study period, the prevalence of multimorbidity increased (47-52%), and polypharmacy remained stable (27%). Polypharmacy, multimorbidity, deprivation and age were independently associated with PIP. Conclusions: Almost a fifth of middle-aged adults prescribed medicines are exposed to PIP, as defined by the PROMPT criteria. This is likely to be linked with exposure to avoidable adverse drug events. The PROMPT criteria may provide a useful aid in interventions to optimise prescribing.


Sign in / Sign up

Export Citation Format

Share Document